GE HealthCare Technologies reported second-quarter organic orders rose 11.1% year over year, with book-to-bill reaching 1.15 times and backlog climbing to a record $23.9 billion. Management said order growth was broad based across every segment with no material one-time items, and the two-year order-growth stack exceeded 7%. Nearly 85% of equipment revenue entering the third quarter was already secured, and the company reaffirmed full-year organic revenue growth guidance of 3% to 4%. Some of the strongest order growth came from longer-cycle radiology products expected to contribute more meaningfully to revenues in 2027, while Patient Care Solutions revenues declined 13.3% year over year with negative segment EBIT due to operational and fulfillment challenges.
GE HealthCare Technologies Inc.Q2 organic orders surged 11.1% with record backlog of $23.9B, indicating strong end-customer demand.
Medtronic PLC
Koninklijke Philips NV